NeoGenomics, Inc. Fair Value Inputs, Long-term Revenue Growth Rate (Deprecated 2018-01-31)
NeoGenomics, Inc. (NEO) reported Fair Value Inputs, Long-term Revenue Growth Rate (Deprecated 2018-01-31) of 37.50% for the 3-month period ending 2014-09-30, per its 10-Q filed 2014-11-04.
Discontinued › Income Statement › Other Income
us-gaap:FairValueInputsLongTermRevenueGrowthRate · last filed 2014-11-04
- NeoGenomics, Inc. fair value inputs, long-term revenue growth rate (deprecated 2018-01-31) for the quarter ending 2014-09-30 was 37.50%.
- NeoGenomics, Inc. fair value inputs, long-term revenue growth rate (deprecated 2018-01-31) for the quarter ending 2014-06-30 was 32.50%.
- NeoGenomics, Inc. fair value inputs, long-term revenue growth rate (deprecated 2018-01-31) for the quarter ending 2014-03-31 was 16.00%.
| Period end | Fair Value Inputs, Long-term Revenue Growth Rate (Deprecated 2018-01-31) 3 month | Fair Value Inputs, Long-term Revenue Growth Rate (Deprecated 2018-01-31) 6 month | Fair Value Inputs, Long-term Revenue Growth Rate (Deprecated 2018-01-31) 9 month |
|---|---|---|---|
| 2014-09-30 | 37.50% 10-Q · filed 2014-11-04 | 28.90% 10-Q · filed 2014-11-04 | |
| 2014-06-30 | 32.50% 10-Q · filed 2014-07-29 | 24.30% 10-Q · filed 2014-07-29 | |
| 2014-03-31 | 16.00% 10-Q · filed 2014-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |